Add to ORKGOne KRAS (Kirsten rat sarcoma viral oncogene homolog) mutation is present in up to of all human tumors, and this is one of the most frequently activated oncogenes(). Recent research has demonstrated that presence of KRAS mutation may directly infl uence medical decisions in patients with colon and lung cancer. Th is review ar-ticle will briefl y discuss the following concepts about Kras oncogene that may be signifi cant for practicing physicians
In recent years, precision medicine has taken an increasing place in various branches of medical onc...
Rat sarcoma virus (RAS) represents the most frequently mutated oncogene family across all malignanci...
Mutations in KRAS are among the most frequent aberrations in cancer, including colon cancer. KRAS di...
The challenge of translational medicine is to translate very complex scientific data into the clinic...
Approximately 30 % of all human cancers have a mutation in the v-Ki-ras2 Kirsten rat sarcoma viral o...
KRAS (kirsten rat sarcoma viral oncogene) is a member of the RAS family. KRAS mutations are one of m...
The KRAS/ K-RAS oncogene is crucially involved in human cancer. The term "oncogene" - i.e., a gene a...
In non-small cell lung cancer (NSCLC) the most common alterations are identified in the Kirsten rat ...
KRAS mutations are one of the most frequent oncogenic mutations of all human cancers, being more pre...
Abstract Colorectal cancer (CRC) is a heterogeneous disease at the cellular and molecular levels. Ki...
The RAS gene family is among the most studied and best characterized of the known cancer-related gen...
Background: Kirsten rat sarcoma (KRAS) gene is a target of genetic alterations which are diagnostic ...
Rat sarcoma (RAS) oncogenes have intensively been investigated during the last decades. Taking into ...
Review on KRAS (Kirsten rat sarcoma viral oncogene homolog), with data on DNA, on the protein encode...
KRAS mutation in adenoma and carcinoma components and clinicopathologic features.</p
In recent years, precision medicine has taken an increasing place in various branches of medical onc...
Rat sarcoma virus (RAS) represents the most frequently mutated oncogene family across all malignanci...
Mutations in KRAS are among the most frequent aberrations in cancer, including colon cancer. KRAS di...
The challenge of translational medicine is to translate very complex scientific data into the clinic...
Approximately 30 % of all human cancers have a mutation in the v-Ki-ras2 Kirsten rat sarcoma viral o...
KRAS (kirsten rat sarcoma viral oncogene) is a member of the RAS family. KRAS mutations are one of m...
The KRAS/ K-RAS oncogene is crucially involved in human cancer. The term "oncogene" - i.e., a gene a...
In non-small cell lung cancer (NSCLC) the most common alterations are identified in the Kirsten rat ...
KRAS mutations are one of the most frequent oncogenic mutations of all human cancers, being more pre...
Abstract Colorectal cancer (CRC) is a heterogeneous disease at the cellular and molecular levels. Ki...
The RAS gene family is among the most studied and best characterized of the known cancer-related gen...
Background: Kirsten rat sarcoma (KRAS) gene is a target of genetic alterations which are diagnostic ...
Rat sarcoma (RAS) oncogenes have intensively been investigated during the last decades. Taking into ...
Review on KRAS (Kirsten rat sarcoma viral oncogene homolog), with data on DNA, on the protein encode...
KRAS mutation in adenoma and carcinoma components and clinicopathologic features.</p
In recent years, precision medicine has taken an increasing place in various branches of medical onc...
Rat sarcoma virus (RAS) represents the most frequently mutated oncogene family across all malignanci...
Mutations in KRAS are among the most frequent aberrations in cancer, including colon cancer. KRAS di...